Tekla Healthcare Investors (HQH) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.008x

Based on the latest financial reports, Tekla Healthcare Investors (HQH) has a cash flow conversion efficiency ratio of 0.008x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($8.72 Million) by net assets ($1.06 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HQH net asset quality score to measure how much of total assets are equity-financed.

Tekla Healthcare Investors - Cash Flow Conversion Efficiency Trend (1996–2014)

This chart illustrates how Tekla Healthcare Investors's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Tekla Healthcare Investors's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Tekla Healthcare Investors Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tekla Healthcare Investors ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Total Gabon
F:RZW
0.045x
Zug Estates Holding AG
SW:ZUGN
0.021x
New Pacific Metals Corp
TO:NUAG
-0.005x
GoGold Resources Inc.
TO:GGD
0.044x
Auto Partner SA
WAR:APR
-0.001x
Trupanion Inc
NASDAQ:TRUP
0.037x
Mader Group Ltd
AU:MAD
0.132x
Ningbo Fuda Co Ltd
SHG:600724
0.048x

Annual Cash Flow Conversion Efficiency for Tekla Healthcare Investors (1996–2014)

The table below shows the annual cash flow conversion efficiency of Tekla Healthcare Investors from 1996 to 2014. For the full company profile with market capitalisation and key ratios, see Tekla Healthcare Investors (HQH) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2014-09-30 $1.05 Billion $-141.08 Million -0.134x -553.81%
2013-09-30 $690.10 Million $20.37 Million 0.030x -42.89%
2012-09-30 $510.40 Million $26.38 Million 0.052x +5.23%
2011-09-30 $378.90 Million $18.61 Million 0.049x +67.01%
2010-09-30 $365.20 Million $10.74 Million 0.029x +493.92%
2009-09-30 $356.30 Million $-2.66 Million -0.007x +53.86%
2008-09-30 $403.00 Million $-6.52 Million -0.016x -39.75%
2007-09-30 $444.00 Million $-5.14 Million -0.012x -8.47%
2006-09-30 $385.10 Million $-4.11 Million -0.011x +16.32%
2005-09-30 $417.10 Million $-5.32 Million -0.013x +3.28%
2004-09-30 $369.30 Million $-4.87 Million -0.013x -13.92%
2003-09-30 $286.80 Million $-3.32 Million -0.012x +25.69%
2002-09-30 $242.00 Million $-3.77 Million -0.016x -109.45%
2001-09-30 $329.40 Million $-2.45 Million -0.007x -39.45%
2000-09-30 $485.60 Million $-2.59 Million -0.005x +59.87%
1998-09-30 $158.00 Million $-2.10 Million -0.013x -65.30%
1997-09-30 $207.70 Million $-1.67 Million -0.008x +41.25%
1996-09-30 $147.60 Million $-2.02 Million -0.014x --

About Tekla Healthcare Investors

NYSE:HQH USA Asset Management
Market Cap
$1.25 Billion
Market Cap Rank
#8633 Global
#2461 in USA
Share Price
$22.60
Change (1 day)
+1.16%
52-Week Range
$15.58 - $22.60
All Time High
$22.60
About

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs funda… Read more